Sana Biotechnology boosts IPO range, looks to raise $517 million

GeekWire

Sana Biotechnology — the Seattle upstart that’s looking to treat a variety of diseases through gene therapy and cell engineering — is generating buzz on Wall Street. That would net the biotechnology company $517 million if it sold at the midpoint of that range.

Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body

GeekWire

Less than three years after it was founded and with no revenue on the books, Sana Biotechnology has f iled to go public. And like many biotechnology companies it is losing money. Startups Biotech IPOs Sana BiotechnologySana CEO Steve Harr (Sana photo).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells

GeekWire

Seattle-based Adaptive Biotechnologies and Microsoft have launched an open-access database called ImmuneCODE to catalog the many ways in which our immune systems fight off a coronavirus infection.

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

GeekWire

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Health/Life Sciences Startups Nautilus Biotechnology parag Mallick Sujal PatelNautilus Photo).

Adaptive Biotechnologies will sell 8M shares to accelerate drug development

GeekWire

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work. Health/Life Sciences Adaptive Biotechnologies

Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation

GeekWire

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC.

Adaptive Biotechnologies posts $26.3M in Q3 revenue, inks partnership with GlaxoSmithKline

GeekWire

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. Tech Adaptive Biotechnologies

Machine learning and microbes: How big data is redefining biotechnology

Tech Republic Big Data

As interesting as big data can be in Silicon Valley, its most fascinating applications often happen elsewhere

U.S. Senate committee revised a draft bill to fund AI, quantum, biotech

Venture Beast

AI Cloud Enterprise VB Home Page biotech biotechnology category-/Business & Industrial category-/Law & Government/Government category-/News Congress draft bill legislation quantum computing semiconductors Senate supply chain White HouseThe U.S.

U.S. Senate committee to consider technology research spending bill

Venture Beast

AI Cloud Enterprise VB Home Page advanced energy artificial intelligence biotechnology category-/Law & Government/Government category-/News/Politics Congress IT spend quantum computing semiconductors tech spendingJoin Transform 2021 this July 12-16. Register for the AI event of the year.

Scientists Dive Into Axolotl Genome, Looking for Secrets to Regeneration

GizModo VR

genome axolotl regeneration genetic mapping human genome organisms biotechnology molecular biology biology salamander branches of biology jeramiah smith genomics elly tanakaIts adorableness aside, the Mexican axolotl is a salamander of particular interest to scientists.

Chimeric Human-Monkey Embryos Kept Alive for a Record 19 Days

GizModo VR

stem cell life sciences weizhi ji developmental biology biotechnology genetically modified organism induced stem cells cloning health medical pharma jeremy bentham biology alan regenberg branches of biology embryo juan carlos izpisua belmonte chimera

Airborne DNA Could Help Scientists Find Elusive Animals

GizModo VR

dna environment elizabeth clare life sciences measurement of biodiversity biology branches of biology environmental dna biotechnology dna sequencing molecular biology naked mole rat

L.A. Records No New Covid Deaths for First Time in Over a Year as Life Gets More Normal

GizModo VR

health medical pharma variants of sars cov 2 covid 19 vaccination in bulgaria life sciences covid 19 vaccination in israel vaccine narendra modi biotechnology barbara ferrer medicine medical research medical specialties vaccination

Living algae facades cover buildings, sucking in CO2 and sun to produce renewable energy

Mashable VR

More about Design , Renewable Energy , Facade , Algae , and Biotechnology. Design Renewable Energy Facade Algae Biotechnology

Mouse Embryos Grow Successfully in Beakers, a Step Toward an Artificial Womb

GizModo VR

artificial womb harman on time radio health medical pharma obstetrics life sciences developmental biology stem cells pokemon biology jose polo biotechnology jacob hanna embryology blastocyst blastoid branches of biology embryo

Oisín raises $5M to develop treatments for ‘zombie cells’ associated with age-related diseases

GeekWire

New funding: Seattle biotech startup Oisín Biotechnologies has raised a $5 million seed round. Health/Life Sciences Startups Biotech Funding Oisin Biotechnologies startupsTwo of Oisín’s three co-founders: CEO Matthew Scholz (left) and Chief Scientific Officer John Lewis. Oisín Photos).

Promising Gene Therapy Trials Suspended Over Potential Cancer Risk

GizModo VR

therapy cancer gene therapy myelodysplastic syndrome thalassemia health medical pharma sickle cell disease life sciences biotechnology molecular biology biology branches of biology gene delivery bluebird

Don't Share Your Vaccine Card on Social Media

GizModo VR

entertainment_culture human interest technology_internet biotechnology vaccination articles life sciences biologyAs more people receive the vaccine, we’re also seeing more of them post photos of their vaccine cards to social media.

Media 83

Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Common DNA Testing Method Has High False-Positive Rate for Rare Mutations, Study Finds

GizModo VR

dna biotechnology molecular biology snp array biology genetics genomics bioinformatics health medical pharma single nucleotide polymorphism genetic testing whole genome sequencing branches of biology

Study 78

Welcome to Hotel Vaccine

GizModo VR

vaccine andrew cuomo kennedy eisenhower clinical medicine elvis charles lindbergh biotechnology johnson johnson cowpox hospitality recreation carter pfizer ford medicine elizabeth joh medical specialties vaccination

The voters will see you now: The finalists for Health Innovation of the Year at the GeekWire Awards

GeekWire

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Adaptive Biotechnologies.

Tech Moves: Amazon’s director of Alexa Trust; BECU adds CIO; Lockstep, Fabric exit stealth mode

GeekWire

Andris Zoltners stepped down from the board of publicly traded Seattle-based Adaptive Biotechnologies after 11 years. . Nautilus Biotechnology Photo). Anne Toth. Amazon Photo).

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

GeekWire

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. Tech Biotech Biotechnology COVID-19 COVID-19 vaccine oncosenx

Adaptive Biotech pushes ahead with new Seattle HQ, showing strength of life sciences industry

GeekWire

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies).

Testing a new COVID-19 test: How T-cells beat antibodies in helping to detect past infections

GeekWire

This was a first-of-its kind diagnostic tool from Seattle-based Adaptive Biotechnologies , a company that develops technology to sequence the human immune system for the diagnosis and treatment of disease. Adaptive Biotechnologies Photo).

Adaptive plans fall launch of T-cell test for past COVID-19 detection, as alternative to antibody tests

GeekWire

Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a study added to the evidence that its approach is more accurate than currently available antibody tests.

Tech Moves: Adriane Brown joins KKR board; AI2 adds HR exec; Ossia and LevelTen hire CFOs; more

GeekWire

Seattle-based Nautilus Biotechnology appointed Human Protein Atlas Director Emma Lundberg to its scientific advisory board. Adriane Brown. Axon Photo). Adriane Brown , managing partner at Seattle VC firm Flying Fish, joined the board of global investment firm KKR.

GeekWire Podcast: What Seattle’s billion-dollar startups say about the region’s tech industry

GeekWire

Podcasts Auth0 convoy Flying Fish Partners Heather Redman Icertis OfferUp outreach Qumulo Remitly Sana Biotechnology Tanium ZenotiSeattle’s billion-dollar tech club, startups with valuations of more than $1 billion. GeekWire Graphic).

Tech Moves: Sea.citi adds board members; another Microsoft vet joins Magic Leap; and more

GeekWire

Seattle-based Adaptive Biotechnologies appointed Leslie Trigg and Katey Owen to its board of directors. Adaptive Biotechnologies’ fourth quarter revenue was up 25% from a year ago. From left: Anna Boone, Janice Dearlove and Maria Karaivanova. Sea.citi Photos).

Adaptive Biotech revenue up 25%; company launches T-cell test for past COVID-19 infections

GeekWire

Seattle-based Adaptive Biotechnologies, which develops technology to sequence the human immune system to diagnose and treat disease, posted revenue of $30.2 Tech Adaptive Biotechnologies chad robins COVID-19 T-cells

.Net 82

Seattle area boasts 10 fast-growing unicorns: Can you name the billion dollar startups?

GeekWire

Sana Biotechnology. Startups Auth0 convoy Icertis OfferUp outreach Qumulo Remitly Sana Biotechnology Tanium unicorns ZenotiThere are 10 unicorn startups in the Seattle area valued at $1 billion or more. Shutterstock Photo).

Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships

GeekWire

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million.

This 35-year-old female CEO is about to crack the glass ceiling, shattering a dismal IPO track record

GeekWire

The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the first woman to guide a company to an initial public offering in Washington state in more than two decades. ” Startups Athira Pharma Biotechnology IPOs leen kawas

Industry slowdown hits Adaptive Biotech’s bottom line as COVID immune initiatives show progress

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

.Net 72

Merck’s multi-billion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

GeekWire

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. Health/Life Sciences Biotechnology Seattle Genetics

Inside the quest for a new COVID-19 test: Microsoft, Adaptive Biotech and the hidden power of immunity

GeekWire

Two companies in the Seattle region, Microsoft and Adaptive Biotechnologies, are on a quest to create a better diagnostic test. Health Tech Podcast Adaptive Biotechnologies chad robins COVID-19 Microsoft Peter Lee

Study 95

Tech Moves: Microsoft’s Brad Anderson jumps to Qualtrics in wave of pre-IPO hires; Elena Donio joins Databricks board; Hiya, Esper add startup vets

GeekWire

Other recent Tech Moves from across the Pacific Northwest: Seattle-based AVM Biotechnology appointed Manon Cox as its new CEO and Gary Grohmann as chief regulatory officer. Longtime Microsoft executive Brad Anderson is moving back to his hometown in Utah as part of his new role at Qualtrics.

SAP 84

Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes

GeekWire

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle. Steve Harr (Sana Photo).

GeekWire Podcast: What pandemic? Tech funding stays strong; Accolade’s IPO; Future of sports

GeekWire

Health/Life Sciences Podcasts Startups Accolade Funding GeekWire Events IPO Sana BiotechnologyHere’s what we’re talking about on the GeekWire Podcast this week. Despite the pandemic, funding for Pacific Northwest tech startups remains robust in the first half of 2020.

U.S. Has Record-Breaking Day With 3.4 Million Vaccinations

GizModo VR

trump health medical pharma drew armstrong kaiser family foundation vaccine biden covid 19 vaccine vaccine diplomacy vaccines biotechnology covid 19 vaccines oxfordastrazeneca covid 19 vaccine medicine clinical trials medical research medical specialties vaccinationToday the U.S.

Harry Potter's invisibility cloak is almost a reality, but only for likely military use

Mashable VR

Canadian camouflage company Hyperstealth Biotechnology is working on a 'cloak' that can render some objects nearly invisible from certain angles. The cloak uses a technology called Quantum Stealth to bend light around people or objects.